ProSymmetry will be attending the Executive Project, Program & Portfolio Management (EP3M) Summit 2026, a biopharma-focused event centered on portfolio prioritization, governance, strategic decision-making, and execution across complex R&D environments. The summit brings together senior portfolio, program, and project leaders from pharmaceutical and biotech organizations to discuss how leading companies are improving portfolio visibility, evaluating investment trade-offs, and strengthening decision quality under uncertainty.

As organizations continue balancing innovation, resource constraints, and increasing pressure to deliver measurable portfolio value, the ability to connect strategy to execution has become increasingly important. EP3M focuses on practical approaches to portfolio governance, scenario planning, AI-supported decision-making, and cross-functional alignment; all critical capabilities for organizations navigating complex development pipelines and shifting priorities.

If you’re attending the summit and focused on improving portfolio prioritization, forecasting capacity impacts, or making more confident portfolio decisions, we’d love to connect and continue the conversation with fellow practitioners and leaders in the space.

If you’re exploring these topics ahead of the event, check out our podcast, What’s the Plan?, where practitioners and portfolio leaders discuss real-world challenges around prioritization, governance, planning, and execution:
https://www.prosymmetry.com/whats-the-plan

Resources for Portfolio & Program Leaders

Strategic portfolio management platform buyer’s guide — key considerations for improving portfolio visibility, prioritization, and decision-making

Guide to portfolio success with scenario planning — evaluate trade-offs, understand capacity impacts, and make more confident portfolio decisions

Deliver what matters: connecting portfolio to outcomes — best practices for aligning portfolios, programs, and projects to measurable business results